Related Experiment Video
Updated: Jun 17, 2026

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation
Yong-Sam Jung1, Gang Liu, Xinbin Chen
1Center for Comparative Oncology, University of California, Davis, California 95616, USA.
Abstract:
DNA polymerase eta (PolH), a Y family translesion polymerase, is required for repairing UV-induced DNA damage, and loss of PolH is responsible for early onset of malignant skin cancers in patients with xeroderma pigmentosum variant (XPV), an autosomal recessive disorder. Here, we show that PolH, a target of the p53 tumor suppressor, is a short-half-life protein. We found that PolH is degraded by proteasome, which is enhanced upon UV irradiation. We also found that PolH interacts with Pirh2 E3 ligase, another target of the p53 tumor suppressor, via the polymerase-associated domain in PolH and the RING finger domain in Pirh2. In addition, we show that overexpression of Pirh2 decreases PolH protein stability, whereas knockdown of Pirh2 increases it. Interestingly, we found that PolH is recruited by Pirh2 and degraded by 20S proteasome in a ubiquitin-independent manner. Finally, we observed that Pirh2 knockdown leads to accumulation of PolH and, subsequently, enhances the survival of UV-irradiated cells. We postulate that UV irradiation promotes cancer formation in part by destabilizing PolH via Pirh2-mediated 20S proteasomal degradation.
Insights
DNA polymerase eta (PolH) protein stability is regulated by UV irradiation and the Pirh2 E3 ligase. PolH degradation by the proteasome is enhanced by UV, impacting skin cancer risk in xeroderma pigmentosum variant patients.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- DNA polymerase eta (PolH) is crucial for repairing UV-induced DNA damage and preventing skin cancer in xeroderma pigmentosum variant (XPV) patients.
- Loss of PolH function is linked to early-onset malignant skin cancers.
- PolH is a target of the p53 tumor suppressor and has a short half-life.
Purpose of the Study:
- To investigate the regulation of PolH protein stability.
- To identify the mechanisms and factors involved in PolH degradation.
- To understand the role of PolH regulation in cellular response to UV damage and cancer development.
Main Methods:
- Assessing PolH protein stability under various conditions.
- Investigating PolH interaction with the Pirh2 E3 ligase using co-immunoprecipitation.
- Analyzing the effect of Pirh2 overexpression and knockdown on PolH stability.
- Examining PolH degradation by the 20S proteasome in a ubiquitin-independent manner.
- Evaluating the impact of Pirh2 knockdown on UV-irradiated cell survival.
Main Results:
- PolH is a short-half-life protein degraded by the proteasome, with degradation enhanced upon UV irradiation.
- PolH interacts with the Pirh2 E3 ligase via specific protein domains.
- Pirh2 overexpression decreases PolH stability, while Pirh2 knockdown increases it.
- PolH is degraded by the 20S proteasome in a ubiquitin-independent manner, facilitated by Pirh2.
- Pirh2 knockdown results in PolH accumulation and enhanced survival of UV-irradiated cells.
Conclusions:
- UV irradiation promotes cancer formation by destabilizing PolH through Pirh2-mediated 20S proteasomal degradation.
- The Pirh2-PolH interaction represents a novel regulatory pathway impacting DNA repair and cancer susceptibility.
- Targeting the Pirh2-mediated degradation of PolH may offer therapeutic strategies for skin cancer prevention and treatment.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure
The proteasome is an...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...

